MDS Nordion helping Avid develop products

MDS Nordion is teaming with Avid Radiopharmaceuticals Inc. to help the Philedelpia-based company develop its Alzheimer's disease detection and monitoring tools.MDS.jpg MDS Nordion, which makes medical isotopes and radiopharmaceuticals for use in molecular medicine, will use its single photon emission computed tomography (SPECT) technology to test Avid's compounds. “This partnership with Avid provides an exciting opportunity to develop a new molecular imaging agent that can assist researchers to identify a more effective therapy for patients with this debilitating disease,” says MDS Nordion president Steve West. “MDS Nordion is using its proprietary technologies to work to develop these important compounds with our pharmaceutical and biopharmaceutical partners.”

Submit a comment

Please leave your name, which will be used to sign your submission to the SCANsite. Thanks for contributing your thoughts. Come back again. Tony Patterson, Editor & CEO.

© 2006 - 2009 SCAN
INTEGRITY INTELLIGENCE INFORMATION
Site by Citadel Rock
SCAN